These studies identified novel splice variants specific for AML patients in comparison to normal cells such as NOTCH2, CD13 and FLT3 [9], but also splice variants discriminating leukemia subgroups such as MAPK15 and PLXNB1 [39]. This evidence concerns the gene NOTCH2 and leukemia.